Clinical trial
Bipolar Disorder in Epilepsy
NCT00365482 · Northwell Health, Other · Completed
Key facts
| NCT number | NCT00365482 |
|---|---|
| Title | Bipolar Disorder in Epilepsy |
| Official title | Bipolar Disorder in Epilepsy |
| Lead sponsor | Northwell Health, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Epilepsy, Bipolar Disorder |
| Enrollment | 102 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Aug 17, 2006 |
| Last update posted | May 17, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: